DANIELLE HARPE: Open Payments
NPI 1205558194 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,771 in 99 payments from 16 companies in 2025. Trend: 2023 $2,175 · 2024 $2,096 · 2025 $1,771
Food & beverage: $1,771
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 45 | $726 |
| Phathom Pharmaceuticals, Inc. | 11 | $162 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $154 |
| Celltrion USA Inc. | 7 | $144 |
| Gilead Sciences, Inc. | 5 | $99 |
| QOL Medical, LLC | 4 | $99 |
| Madrigal Pharmaceuticals | 3 | $68 |
| PFIZER INC. | 4 | $62 |
| GENZYME CORPORATION | 2 | $60 |
| Ardelyx, Inc. | 2 | $38 |
Products named: MAVYRET, LINZESS, CREON, VOQUEZNA, VEGZELMA, XIFAXAN, Sucraid, DUPIXENT.
Industry payments across TX — which companies pay providers there.
